Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | acetylcholinesterase | 0.0136 | 0.0197 | 0.0197 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0136 | 0.0197 | 0.0197 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0136 | 0.0197 | 0.0197 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0282 | 0.2319 | 1 |
Echinococcus multilocularis | neuroligin | 0.0136 | 0.0197 | 0.0197 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0282 | 0.2319 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0807 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0242 | 0.1742 | 0.1576 |
Trypanosoma brucei | metallo- peptidase, Clan MG, Family M24 | 0.0301 | 0.2596 | 0.5 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0807 | 1 | 1 |
Schistosoma mansoni | methionyl aminopeptidase 1 (M24 family) | 0.0282 | 0.2319 | 0.2319 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0282 | 0.2319 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 1 (M24 family) | 0.0301 | 0.2596 | 0.2596 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0136 | 0.0197 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0253 | 0.1894 | 0.1731 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0136 | 0.0197 | 0.0197 |
Loa Loa (eye worm) | carboxylesterase | 0.0807 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.0807 | 1 | 1 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0301 | 0.2596 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0243 | 0.1758 | 0.1592 |
Loa Loa (eye worm) | methionine aminopeptidase type I | 0.0301 | 0.2596 | 0.2447 |
Plasmodium vivax | methionine aminopeptidase 1b, putative | 0.0301 | 0.2596 | 1 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0136 | 0.0197 | 0.0197 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0807 | 1 | 1 |
Echinococcus granulosus | methionyl aminopeptidase 1 M24 family | 0.0301 | 0.2596 | 0.2596 |
Brugia malayi | Carboxylesterase family protein | 0.0807 | 1 | 1 |
Onchocerca volvulus | 0.0136 | 0.0197 | 0.5 | |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0136 | 0.0197 | 0.0197 |
Onchocerca volvulus | 0.0136 | 0.0197 | 0.5 | |
Brugia malayi | Methionine aminopeptidase protein type I | 0.0301 | 0.2596 | 0.2447 |
Plasmodium falciparum | methionine aminopeptidase 1b, putative | 0.0301 | 0.2596 | 1 |
Echinococcus granulosus | neuroligin | 0.0136 | 0.0197 | 0.0197 |
Echinococcus multilocularis | acetylcholinesterase | 0.0807 | 1 | 1 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0301 | 0.2596 | 0.5 |
Echinococcus granulosus | carboxylesterase 5A | 0.0807 | 1 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 1 (M24 family) | 0.0282 | 0.2319 | 0.2319 |
Toxoplasma gondii | methionine aminopeptidase | 0.0301 | 0.2596 | 1 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0282 | 0.2319 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0136 | 0.0197 | 0.0197 |
Onchocerca volvulus | 0.0136 | 0.0197 | 0.5 | |
Trypanosoma brucei | methionine aminopeptidase, type I, putative | 0.0301 | 0.2596 | 0.5 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0136 | 0.0197 | 0.0197 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0243 | 0.1758 | 0.1592 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0282 | 0.2319 | 1 |
Leishmania major | methionine aminopeptidase, putative,metallo-peptidase, Clan MG, Family M24 | 0.0301 | 0.2596 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.0807 | 1 | 1 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0136 | 0.0197 | 0.0197 |
Trypanosoma brucei | methionine aminopeptidase, putative | 0.0301 | 0.2596 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0282 | 0.2319 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0136 | 0.0197 | 0.0197 |
Loa Loa (eye worm) | nuclear hormone receptor-like 1 | 0.0243 | 0.1758 | 0.1592 |
Onchocerca volvulus | 0.0136 | 0.0197 | 0.5 | |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0282 | 0.2319 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0807 | 1 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0143 | 0.0288 | 0.0288 |
Loa Loa (eye worm) | hypothetical protein | 0.0807 | 1 | 1 |
Schistosoma mansoni | methionyl aminopeptidase 1 (M24 family) | 0.0282 | 0.2319 | 0.2319 |
Onchocerca volvulus | 0.0136 | 0.0197 | 0.5 | |
Schistosoma mansoni | thyroid hormone receptor | 0.0143 | 0.0288 | 0.0288 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0136 | 0.0197 | 0.0197 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0282 | 0.2319 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0143 | 0.0288 | 0.0288 |
Schistosoma mansoni | gliotactin | 0.0136 | 0.0197 | 0.0197 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0136 | 0.0197 | 0.5 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0807 | 1 | 1 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0282 | 0.2319 | 0.5 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0136 | 0.0197 | 0.0197 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.